• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 211/18 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms

Patent holdings for IPC class C07D 211/18

Total number of patents in this class: 146

10-year publication summary

7
6
18
13
9
7
10
5
9
3
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
The United States of America, as represented by the Secretary, Department of Health and Human Services
2822
5
Massachusetts Institute of Technology
9942
4
BioLegend, Inc.
51
4
Toyama Chemical Co., Ltd.
103
4
Vividion Therapeutics, Inc.
32
4
Bristol-myers Squibb Company
4848
3
F. Hoffmann-La Roche AG
7889
3
California Institute of Technology
3953
3
The Broad Institute, Inc.
1753
3
Incyte Holdings Corporation
652
3
Research Triangle Institute
408
3
Schering Corporation
484
3
SRX Cardio, LLC
21
3
Taisho Pharmaceutical Co., Ltd.
853
3
AstraZeneca AB
2934
2
Boehringer Ingelheim International GmbH
4732
2
Syngenta Crop Protection AG
5891
2
Bayer Pharma AG
1058
2
Abbvie Inc.
1783
2
Agro-kanesho Co., Ltd.
48
2
Other owners 86